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Abstract
Background: Apo A-I deficiency clinically shows low serum levels of HDL cholesterol and corneal opacity at a
young age. Histopathological evaluations of affected corneas are not enough, and the mechanism of corneal
opacity is still unclear.
Case presentation: A 61-year-old woman suffered from blurred vision with a corneal opacity. She had significantly
reduced serum levels of high-density lipoprotein cholesterol and Apo A-I, stenosis of the coronary arteries, and ischemic
heart failure. On genetic examination, a homozygous mutation of Apo A-ITsukuba was identified. Histopathological
examination of the corneal button after PKP showed numerous vesicles in the corneal stroma, which were more
prominent in the deep stroma than in the shallow stroma. Collagen VI was observed in some of those vesicles.
Conclusion: We experienced a rare case of corneal opacity due to Apo A-I deficiency. Our histopathological findings
indicated that structural changes in corneal collagen fibrils contribute to the formation of stromal vesicles.
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Background
Apo A-I is an essential component of HDL. Its defi-
ciency is clinically detected by low serum levels of HDL
cholesterol. Although different gene mutations of Apo
A-I are reported [1–4], the typical clinical presentation
includes corneal opacity, xanthoma, and ischemic heart
disease at a young age. Histopathological evaluations of
affected corneas are not enough, and the mechanism of
corneal opacity is still unknown. In the present study,
we report a part of the mechanism associated with
corneal opacity in a case of genetic Apo A-I deficiency.
Case presentation
In 2012, a 61-year-old woman with blurred vision pre-
sented with corneal opacity of the left eye. Her visual
acuity was 20/40 OS and 20/20 OD. She had been
diagnosed with HDL deficiency at the age of 46 years,
1997. but she had been off treatment for about 10 years.
She had undergone PKP of the right eye for the same
symptoms when she was 58 years old, 2009.
The patient was the fourth of 8 siblings. A brother
died in an accident and a sister died in childhood. None
of her family members had been diagnosed with HDL
deficiency, and there was no family history of consan-
guineous marriage. On physical examination, she had
bilateral xanthomas of the eyelids and focal yellow skin
discolorations in the cubital fossae of both forearms, but
there was no tonsillar hypertrophy or Achilles tendon
xanthoma.
Blood tests showed an extremely low HDL-cholesterol
level (6 mg/dL) with undetectable Apo A-I (<5 mg/dL).
Levels of Apo B and Apo E were slightly elevated
(109 mg/dL and 5.8 mg/dL, respectively). Serum triglycer-
ide, total cholesterol, low-density lipoprotein cholesterol,
and lecithin-cholesterol acyltransferase levels were within
the normal limits. A genetic evaluation was performed as
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previously described [4], and showed that she was
homozygous for the Apo A-ITsukuba mutation, which is a
single-nucleotide insertion of cytosine that alters the
reading frame from codon 5 and produces a premature
stop codon at codon 34 (Fig. 1). Thus, this patient was
diagnosed with genetic Apo A-I deficiency. Electrocardio-
gram, echocardiogram, and myocardial scintigraphy
showed significant ischemic heart failure and angiography
showed severe stenosis of the coronary arteries. Conse-
quently, she underwent percutaneous coronary interven-
tion and coronary artery bypass grafting.
On slit-lamp examination, there was a diffuse corneal
stromal opacity with a lucid zone in the left eye.
Confocal microscopy (Heidelberg Retinal Tomograph
Rostock Cornea Module, Heidelberg Engineering, Heidelberg,
Germany) revealed high-intensity vesicles (10–100 μm in
diameter) in the corneal stroma (Fig. 2). In 2013, PKP
was performed for the left eye, and the corneal
button tissues were examined histopathologically and
immunohistochemically.
Histopathological and immunohistochemical analysis of
the corneal button
The cornea showed normal thickness and there was
no significant abnormality of the epithelium, Bow-
man’s layer, or the endothelium. There were numerous
small vesicles in the corneal stroma (Fig. 3a), which
were of similar size to the vesicles observed with
confocal microscopy. The vesicles were more promin-
ent in the deep stroma than in the shallow stroma.
Accumulations in the vesicles were Congo-red nega-
tive and alcian-blue positive (Fig. 3b). Sudan III and
Sudan black staining could not confirm the presence
of cholesterol ester in the vesicles. On immunohisto-
chemical analysis, collagen VI [clone: anti-hCL (VI),
mouse IgG1,κ; 1:500; KYOWA PHARMA CHEMICAL
CO., LTD., Toyama, Japan] was observed in some
vesicles (Fig. 3c).
Since the PKP, the patient has been on regular medica-
tion with pitavastatin and tocopherol nicotinate and has
had a normal lipid profile except for low serum HDL-
Fig. 1 The result of genetic evaluation. A single-nucleotide insertion of cytosine altered the reading frame from codon 5 and produces a prema-
ture stop codon at codon 34
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Fig. 2 Confocal microscopy in the corneal stroma. High-intensity vesicles, 10 to 100 μm in diameter, were observed
Fig. 3 Histopathology and immunohistochemistry of the surgically excised corneal button. a Histopathology of the central cornea. There were
many small vesicles (10 to 100 μm in diameter) the corneal stroma. The vesicles were much more numerous in the deep stroma than in the
upper stroma (hematoxylin and eosin staining; magnification × 40). b Histopathology of the central cornea. Accumulations in the vesicles were
alcian-blue positive (alcian-blue staining; magnification × 40). c Collagen VI immunostaining of the central cornea detected collagen VI in some of
the vesicles (magnification × 40)
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cholesterol levels. In 2015, her current visual acuity is
20/25 OS and 20/20 OD and both corneal grafts have
maintained good transparency.
Discussion
Our patient demonstrated clinical findings typical to
Apo A-I deficiency. Histopathologically, vesicles in the
corneal stroma were significantly larger (10–100 μm
in diameter) than those described in the report by
Osakabe and colleagues (200 nm–2 μm in diameter)
[5]. Apo A-I mutations, including Apo A-IIowa, are
known to induce amyloidosis [6]. However, our
patient did not have any accumulation of amyloid in
the corneal stroma. It is possible that we failed to
detect cholesterol ester in the vesicles by Sudan black
staining because we embedded the corneal button in
paraffin. It was also regretful that the right cornea
had not been examined immunohistochemically.
Collagen VI is a major extracellular matrix protein,
bridging cells to the surrounding connective tissue and
organizing the three-dimensional tissue architecture.
The mutations in the genes encoding Collagen VI chains
result in several forms of inherited myopathies, decrease
of stiffness in cartilage [7]. It is also distributed in corneal
stroma, and reported the change of its expression level
during wound healing period [8–10].
Conclusions
To our knowledge, ours is the first report of a patient
with confirmed mucoid degeneration and accumulations
of collagen VI in the stromal vesicles. Our results suggest
that structural changes in corneal collagen fibrils contribute
to the formation of stromal vesicles.
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